Jump to start of content

ABIM's call center wait times may be longer than usual Expand/Collapse the ABIM alert.

Due to high volume, ABIM call center wait times may be longer than usual. You may also contact us via email at request@abim.org. We apologize for any inconvenience this may cause.

Breadcrumb trail:

Nephrology Approval Committees

Longitudinal Knowledge Assessment

Expand All | Collapse All

Rajnish Mehrotra, MD, Chair

Dr. Mehrotra, board certified in Internal Medicine and Nephrology, is Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and Chief of the Division of Nephrology and Hypertension at Harbor-UCLA Medical Center. He chairs the Dialysis Advisory Group of the American Society of Nephrology.

Dr. Mehrota is a member of the American Board of Internal Medicine Nephrology Board Exam Committee. He has been admitted to Alpha Omega Alpha, an honorary medical society, and was awarded the John Maher Award by the International Society for Peritoneal Dialysis in 2006. His research support includes, among others, grants from the National Institutes of Health and the American Heart Association. His research interests include determinants of selection of dialysis modality, outcome studies in peritoneal dialysis, and mineral metabolism in chronic kidney disease. Dr. Mehrotra has published/co-authored over 120 articles and/or book chapters.

He is an Associate Editor of NephSAP, Section Editor for Clinical Nephrology, and serves as a member of the editorial board of Journal of American Society of Nephrology, Kidney International, Clinical Journal of American Society of Nephrology, Peritoneal Dialysis International and Journal of Renal Nutrition. He chairs the Education Committee of the International Society for Peritoneal Dialysis and is a member of the Board of Directors for the International Society for Hemodialysis.

He received his medical degree from All India Institute of Medical Sciences in New Delhi. He completed his internship and residency training at the Medical College of Pennsylvania/Hahnemann University – Drexel University College of Medicine, Philadelphia, Pennsylvania and fellowship training at the University of Missouri-Columbia.

As of August 2021, Dr. Mehrota reported the following external relationship:

Industry-supported continuing medical education supported by the following, with compensation as listed:

  • Baxter, to support Home Dialysis University, an educational course for practicing physicians to teach principles of peritoneal and home hemodialysis, receiving reimbursement for travel expenses and honoraria. Continuing medical education for this activity is provided by Wake Forest University.

Work as an author or editor for following companies, with compensation as listed:

  • American Society of Nephrology, Editor-in-Chief, Clinical Journal of the American Society of Nephrology, receiving a stipend.
  • Journal of Renal Nutrition, Editorial Board

Dr. Mehrotra serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Northwest Kidney Centers, Member Board of Trustees, receiving no compensation.

Diane Cibrik, MD, MS

As of October 2021, Dr. Cibrik reported the following external relationships:

Service on a research-related advisory board or expert panel for the following company, with honoraria:

  • CareDx
  • ITBmed

Talat Ikizler, MD, FASN

Dr. Ikizler is the Director of Division of Nephrology and Hypertension and Professor of Medicine at the Vanderbilt University School of Medicine (VUSM) in Nashville, Tennessee. He currently serves as a Nephrology Longitudinal Approval Committee member at the American Board of Internal Medicine. He also holds the Catherine McLaughlin Hakim Chair in Vascular Biology. He is a member of the American Society of Clinical Investigation, Association of American Physicians, and Federation of American Societies for Experimental Biology Board of Directors. He has significant research and clinical interest in nutritional and metabolic aspects of acute and chronic disease states.

Dr. Ikizler was the Medical Director and Chief Executive Officer of the Vanderbilt University Medical Center Outpatient Dialysis unit between 2000 and 2012. He is currently an Associate Editor for Kidney International, and he was the past President of International Society of Renal Nutrition and Metabolism 2010 – 2012 and National Kidney Foundation of Middle Tennessee 2002 – 2004, an Associate Editor for Journal of American Society of Nephrology 2006-2012, Director of the Master of Science in Clinical Investigation Program at VUSM 2005 - 2017 and Member and Chair of American Board of Internal Medicine Nephrology Test Writing Committee 2008 - 2018. He is the recipient of National Kidney Foundation Joel Kopple Award, International Society of Renal Nutrition and Metabolism Thomas Addis Award and VUSM Excellence in Mentoring Translational Scientist Award. He has published over 250 original articles, 50 editorial reviews and 20 book chapters. He is the co-Editor of Handbook of Nutrition in Kidney Disease and Chronic Kidney Disease, Dialysis, and Transplantation.

Dr. Ikizler earned his medical degree and completed his internships in surgery, pediatrics, psychiatry and obstetrics/gynecology at Istanbul University. He completed his residency at Sisli Etfal Hospital, also in Istanbul, Turkey. He completed his nephrology fellowship at VUMC.

As of April 2022, Dr. Ikizler reported the following external relationships:

Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:

  • Frensius, for nutrition-related research, receiving reimbursement for travel expenses and honoraria.
  • Nestle, receiving reimbursement for travel expenses and honoraria.
  • LaRenon Nutrition, receiving honoraria.
  • Abbott, receiving honoraria.

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation as an editor.

Dr. Ikizler serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • International Society of Nephrology, Associate Editor, receiving honoraria and reimbursement for travel expenses.

John Sperati, MD

Dr. Sperati is an assistant professor of medicine in the Division of Nephrology at The Johns Hopkins University School of Medicine. He is an associate program director of the Osler Medicine Residency Training Program. He is board certified in Internal Medicine and Nephrology.

Dr. Sperati is a member of the American Board of Internal Medicine (ABIM) Nephrology Self-Assessment Committee. He served as an examination beta-tester for the ABIM Nephrology Self-Assessment Exam from 2008 to 2015. He is a fellow of the National Kidney Foundation (NKF) and serves as a member of the NKF Education Committee. Dr. Sperati was on the program committee for the NKF Spring Clinical Meetings from 2010 to 2012 and has served as a key informant to the Agency for Healthcare Research and Quality. He also served on the American Heart Association working group that drafted management guidelines and scientific priorities for fibromuscular dysplasia.

Dr. Sperati is on the editorial board of Advances in Chronic Kidney Disease. He is a section editor of Current Hypertension Reports and has been an author and section editor for The Johns Hopkins Internal Medicine Board Review.

Dr. Sperati received his medical degree from The Pennsylvania State University College of Medicine in State College, Pennsylvania. He completed his residency in internal medicine at The Johns Hopkins University School of Medicine in Baltimore, Maryland. He served as an Assistant Chief of Service at The Johns Hopkins Hospital and completed a fellowship in nephrology at Hopkins. He holds a master’s degree in clinical epidemiology from The Johns Hopkins Bloomberg School of Public Health.

As of October 2021, Dr. Sperati reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Johns Hopkins University, from the following company:

  • Novartis

Dr. Sperati serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • National Kidney Foundation, Education Committee Member, without compensation.

Traditional, 10-Year MOC Exam

Expand All | Collapse All

Bernard G. Jaar, MD, Chair

Bernard G. Jaar, MD, ChairDr. Jaar is in private practice with the Nephrology Center of Maryland in Baltimore and is an Assistant Professor of Medicine in the Division of Nephrology, Department of Medicine at the Johns Hopkins School of Medicine with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. He is also an Associate Faculty Member of the Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Medical Institutions. He is board certified in Nephrology.

Dr. Jaar is a member of the American Board of Internal Medicine Nephrology Board Exam Committee. He has served on the editorial board of several nephrology journals and is currently the Section Editor for Epidemiology and Outcomes Research for BioMed Central (BMC) Nephrology. He is the past Chair of the Medical Advisory Board and of the Grant Review Committee of the National Kidney Foundation of Maryland (NKFM). He is a member of the Board of Directors of the NKFM; he is also a member of National Kidney Foundation's Dialysis Outcomes Quality Initiative Education Committee. He is a member of the State of Maryland Commission on Kidney Disease and a Fellow of the American Society of Nephrology and of the National Kidney Foundation. He received the President's Award and Volunteer of Year Award from the NKFM. He also received the Section Editor of the Year Award (2014) from BMC, London, England.

Dr. Jaar received his medical degree from the State University of Haiti. He completed house staff training at the Assistance Publique – Hôpitaux de Paris, in Paris, France and obtained a nephrology degree from Paris 5 Descartes University before moving to the United States. He completed again his house staff training in internal medicine at the Graduate Hospital in Philadelphia and a fellowship in nephrology at the Johns Hopkins Hospital in Baltimore. He holds a master of public health degree from the Johns Hopkins Bloomberg School of Public Health.

As of August 2021, Dr. Jaar reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

  • BioMed Central Nephrology, Section Editor, without compensation.
  • UpToDate®, receiving compensation for co-authorship of a chapter on lead-related nephrotoxicity.
  • Springer Nature, Member of Editors' Advisory Group for BMC Series.

Dr. Jaar serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • National Kidney Foundation of Maryland, past Chairman, Medical Advisory Board; past Chairman, Research Grant Committee, without compensation.
  • National Kidney Foundation, Education Committee Member, without compensation.

Phyllis August, MD

Phyllis August, MDDr. August is the Ralph A. Baer MD Professor of Research in Medicine, and a Professor of Medicine, Public Health, and Medicine in Obstetrics and Gynecology at Weill Cornell Medicine. She is an Attending Physician at New York Presbyterian (NYP) Hospital-Weill Cornell, the Director of the NYP-Weill Cornell Hypertension Center, the Program Director for the Nephrology Fellowship training program at NYP Weill Cornell and the Director of the Theresa and Eugene Lang Center for Research and Education at New York Presbyterian Queens. She is board certified in both Internal Medicine and Nephrology.

Dr. August has been involved in clinical practice and clinical investigation related to hypertension, particularly in the context of pregnancy and/or kidney disease for over 30 years. She has been a member of several committees that have developed guidelines for the treatment of these conditions including The American College of Obstetricians and Gynecologist's Task Force, The National High Blood Pressure Education Program Working Group on Hypertension and Pregnancy, and the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure V and VI. Dr. August is an Associate Editor of the Journal of the American Society of Nephrology. She is a member of the American Board of Internal Medicine Nephrology Board Exam Committee and the Medical Board of the Preeclampsia Foundation, and a former member of the Post-Graduate Education Committee for the American Society of Nephrology.

Dr. August received a bachelor's degree in biology from Harvard College, her medical degree from Yale University, and her master of public health degree from the Harvard School of Public Health. She completed house staff training at Yale New Haven Hospital and the New York Hospital, and a fellowship in nephrology and hypertension at the New York Hospital/Weill Cornell.

As of October 2021, Dr. August reported the following external relationships:

Service on data and safety monitoring boards for the following company, with compensation as listed below:

  • Medtronic, for renal denervation study in patients with treatment-resistant hypertension, receiving honoraria.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with honoraria:

  • Bayer, Member, Event Adjudication Committee for a clinical trial.

Work as an author or editor for the following company, with compensation as listed below:

  • UpToDate®, for compensation as an author.

Edgar V. Lerma, MD

Dr. Lerma, who is board certified in Nephrology, is Clinical Professor of Medicine with the University of Illinois College (UIC) of Medicine in Chicago, Illinois. He is also the Educational Coordinator for Nephrology at the UIC/Advocate Christ Medical Center Internal Medicine Residency Training Program in Oak Lawn, Illinois.

He is a member of Associates in Nephrology, S.C., which is a 30+ group of practicing clinical nephrologists serving the suburbs of Chicago and northwest Indiana and has an active and very busy clinical practice. Having previously served as Chair of the American Board of Internal Medicine (ABIM) Nephrology Self-Assessment Committee, he has been an inaugural member of the ABIM Item Writing Development Task Force for Nephrology and continues to serve in this role at present. He also serves as the Education Committee Chair of the American Society of Diagnostic and Interventional Nephrology (2018-20). Recently, he was appointed as the KDIGO (Kidney Disease: Improving Global Outcomes) Knowledge Translation Chair.

He is a previous member of the American Society of Nephrology's (ASN) Committee on Education and also participated in the development of several self-assessment projects, including the National Lipid Association's NLA-SAP, ASN's KSAP and as a peer reviewer for ASN's NephSAP. He previously served as Director of Research for the UIC/Advocate Christ Medical Center Internal Medicine Residency Training Program.

A frequently requested speaker, Dr. Lerma serves on a number of editorial boards, as Associate Editor for Journal of Clinical Lipidology and Clinical Reviews in Bone and Mineral Metabolism, and as Section Editor for Geriatric Nephrology for International Urology and Nephrology. In addition, he has authored several peer-reviewed publications and book chapters. He has also edited several books. Dr. Lerma received a bachelor’s degree in biology from the University of Santo Tomas (UST) College of Science and medical degree from the UST Faculty of Medicine and Surgery in Manila, Philippines. He did his internal medicine residency training at UIC/Mercy Hospital and Medical Center and fellowship training in nephrology and hypertension at Northwestern University/Feinberg School of Medicine in Chicago, Illinois.

As of October 2021, Dr. Lerma reported the following external relationship:

Service on a research-related expert panel or advisory board for the following company, with honoraria:

  • Bayer
  • Takeda
  • Vifor
  • Otsuka

Teaching in satellite symposia funded by the following companies, with compensation for travel expenses and honoraria:

  • AcademicCME
  • Bayer
  • AstraZeneca

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation as an editor.
  • UpToDate®, receiving compensation for authorship.
  • Wolters Kluwer, receiving compensation as an editor.
  • Springer, receiving compensation as an editor.
  • McGraw Hill, receiving compensation as an editor.

Dr. Lerma serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Heart Association (AHA), Member of Leadership Group of AHA Council on Kidney and Cardiovascular Diseases, without compensation.
  • Kidney Disease: Improving Global Outcomes, Knowledge Translation Lead, without compensation.

John C. Lieske, MD

John C. Lieske, MDDr. Lieske, board certified in Internal Medicine and Nephrology, is Professor of Medicine at the Mayo Clinic College of Medicine, and the Director of the Renal Function Laboratory in the Department of Laboratory Medicine and Pathology at the Mayo Clinic. He is also Principal Investigator for the Mayo Clinic O'Brien Urology Research Center; Assistant Director for the Rare Kidney Stone Consortium and Director of the Dent Disease component; and Principal Investigator for the Mayo National Institute of Health (NIH) Nephrology Training Grant. From 1993 to 2000, Dr. Lieske was a faculty member at the University of Chicago before being recruited to Mayo Clinic in 2000.

He has a longstanding interest in urinary proteomics and nephrolithiasis, including NIH-funded projects to investigate inhibitors of crystal aggregation, growth and adhesion to tubular cells; epidemiology of nephrolithiasis; genetics of nephrolithiasis; and mechanisms of enteric hyperoxaluria. As Director of the Renal Function Lab, Dr. Lieske has also developed expertise regarding renal markers of renal disease, including tandem mass spectrometry-based assays for urinary biomarkers and validation of newer markers of injury and kidney function (e.g., cystatin C, NGAL). Dr. Lieske has previously conducted clinical trials regarding the role of diet and probiotics in patients with and without enteric hyperoxaluria. He has also studied the epidemiology of enteric hyperoxaluria and kidney disease after bariatric surgery.

He serves as a member of the American Board of Internal Medicine Nephrology Board Exam Committee.

Dr. Lieske earned a bachelor's degree in biomedical engineering at Northwestern University and his medical degree at the University of Chicago. He did fellowships at the University of Chicago in research nephrology and clinical nephrology, and residency training and internship at Emory University.

As of July 2021, Dr. Lieske reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the Mayo Clinic, from the following companies:

  • Allena, study of an oxalate-degrading enzyme in hyperoxaluric kidney stone formers.
  • OxThera, for a trial of oxalobacter to treat primary hyperoxaluria.
  • Siemens, for a clinical trial.
  • Dicerna, for a clinical trial.
  • Alnylam, for a clinical trial on potential siRNA therapy for primary hyperoxaluria.

Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following companies

  • Alnylam, participating in a study kick-off meeting, receiving reimbursement for travel expenses.
  • Allena, participating in a study kick-off meeting, receiving reimbursement for travel expenses.

Service on data and safety monitoring boards for the following companies, without compensation:

  • Alnylam, for a Phase I/II study.

Service on a research-related expert panel or advisory board for the following companies, with honoraria:

  • Alnylam
  • Ofran
  • Synlogic
  • Novobiome
  • Dicerna

Dr. Lieske serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Oxalosis and Hyperoxaluria Foundation, member of Scientific Advisory Board, receiving reimbursement for travel expenses.

Michal L. Melamed, MD

Dr. Melamed is currently an Associate Professor of Medicine and Epidemiology & Population Health at the Albert Einstein College of Medicine/Montefiore Medical Center. She is also the Nephrology Fellowship Training Program Director and is a Principal Investigator on the NIH Nephrology Training Grant. She is board certified in both Internal Medicine and Nephrology.

Dr. Melamed is currently a member of the American Board of Internal Medicine Nephrology Board Exam Committee. She is also the Program Chair for the New York Society of Nephrology. She has served on the Program Committees of both the National Kidney Foundation and the American Society of Nephrology annual meetings. She works as a clinical investigator studying risk factors for the progression of kidney disease. Dr. Melamed has published more than 80 original scientific communications in the scientific literature. She serves on the Editorial board of the Clinical Journal of the American Society of Nephrology.

Dr. Melamed received a bachelor’s degree from New York University’s College of Arts and Sciences where she was elected to Phi Beta Kappa and graduated summa cum laude. She received her medical degree at the Johns Hopkins University School of Medicine where she was elected to Alpha Omega Alpha. She received her master’s in health sciences degree from the Johns Hopkins Bloomberg School of Public Health. She completed her house staff and nephrology fellowship training at the Johns Hopkins Hospital.

As of October 2021, Dr. Melamed reported the following external relationships:

Dr. Melamed serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • New York Society of Nephrology, President, without compensation.

Silas Norman, MD

Dr. Norman is the current Co-Medical Director of Kidney and Pancreas transplantation at the University of Michigan. He is board certified in Nephrology. Since 2003 he has worked as a transplant nephrologist at the University of Michigan Transplant Center.

Dr. Norman is the Director of the Transplant Multi-Specialty Clinic and Kidney Transplant Outreach Clinics. He is also a long-standing member on the medical school Admissions Executive Committee.

Dr. Norman is a member of the Michigan Medicine Clinical Excellence Society. He is on the Board of the National Kidney Foundation of Michigan and the Board of Trustees for the American Kidney Fund. He currently serves as a member of the Nephrology Board Exam Committee at the American Board of Internal Medicine. He previously served for more than a decade on a number of committees for the United Network for Organ Sharing (UNOS) including the Minority Affairs, Policy Oversight and Kidney Transplantation Committees and the UNOS Board of Directors. He has served as a reviewer for the American Journal of Transplantation, the Journal of the American Society of Nephrology and Clinical Transplantation.

Dr. Norman received his bachelor’s degree in psychology from The University of Michigan and his medical degree from Wayne State University. He completed his residency training at Baylor College of Medicine in Houston, Texas. He completed his nephrology; transplant nephrology and Master of Public Health degree at the University of Michigan.

As of July 2021 Dr. Norman reported the following external relationships:

Funding for salary support, clinical trial expenses and staff, paid to the University of Michigan, from the following companies:

  • Astellas, for a study of bleselumab for prevention of Focal Segmental Glomerulosclerosis.
  • AlloVir, for a study of ALVR10 to prevent life-threatening infections and diseases post-transplantation.
  • Natera, for a study of a transplant rejection test that uses a blood draw to assess the risk of rejection of a transplanted kidney.

Dr. Norman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • National Kidney Foundation of Michigan, Member, without compensation.
  • American Kidney Fund, Member, receiving reimbursement for travel expenses.
  • Detroit Minority Organ Tissue Transplant Education Program, Foundation Board Member, without compensation.
  • American Society of Transplantation, Inclusion, Diversity, Equity, and Access (to Life) (IDEAL) Taskforce Member, without compensation.